Adults who drank two to three cups of coffee a day over decades faced a substantially lower chance of developing dementia, according to a Harvard-led study that tracked 131,821 health professionals for up to 43 years. The research, published in JAMA under the title “Coffee and Tea Intake, Dementia Risk, and Cognitive Function,” recorded 11,033 dementia cases across the study period and found the strongest protective association in participants younger than 75. The findings add weight to a growing body of evidence linking moderate caffeine consumption to brain health, though the observational design stops short of proving that coffee itself prevents cognitive decline.
Four decades of data on coffee and brain health
The study drew on the Health Professionals Follow-up cohort, a long-running research effort that enrolled male dentists, pharmacists, veterinarians, optometrists, osteopathic physicians, and podiatrists beginning in 1986. That cohort, combined with parallel nursing cohorts, gave researchers a uniquely detailed dataset: repeated dietary questionnaires collected every four years, validated medical records, and decades of follow-up that most nutrition studies cannot match.
Within this population, the researchers cataloged caffeinated and decaffeinated coffee intake alongside tea consumption and then tracked which participants later received a dementia diagnosis. The resulting paper, available through the PubMed database, reported 11,033 confirmed dementia cases across the full follow-up window. That case count is large enough to detect relatively modest differences in risk between consumption groups, which is one reason the findings have drawn attention from clinicians and public health researchers alike.
According to a secondary summary from ScienceDaily, the data showed that drinking two to three cups of coffee per day, roughly equivalent to 250 to 300 milligrams of caffeine, was associated with a 35% lower risk of dementia, with the strongest signal appearing in adults under age 75. A separate analysis from Harvard Health Publishing reported a more conservative figure: approximately 18% lower dementia risk among the highest caffeinated-coffee consumers compared with those who drank little or none. Both summaries point back to the same JAMA analysis of coffee and tea intake and long-term cognitive outcomes.
What remains uncertain
The gap between those two numbers, 35% and 18%, reflects different ways of slicing the same dataset rather than a direct contradiction. The 35% figure, per ScienceDaily, applies specifically to the two-to-three-cup-per-day group among adults younger than 75. The 18% figure, per Harvard Health, describes the broadest comparison between top coffee drinkers and minimal consumers across the full age range. Both numbers originate from the same JAMA paper, but they answer slightly different questions, and neither has been independently replicated in a separate cohort.
The observational design is the most significant limitation. Participants who drink moderate amounts of coffee may also exercise more, sleep better, or carry genetic profiles that independently protect against dementia. The researchers adjusted for known confounders such as smoking, body mass index, and alcohol intake, but residual confounding is impossible to eliminate in this type of study. Harvard Health’s own write-up stressed this point, noting that the results do not establish a causal link between coffee and reduced dementia risk.
Full statistical methods and code from the JAMA paper remain behind the journal’s access wall, and the exact caffeine-dose calculations that translate milligrams into cups have not been released in primary form. The 250-to-300-milligram conversion cited by ScienceDaily is a secondary interpretation, not a figure drawn directly from the published tables. Readers should treat that translation as approximate and remember that cup size, brew strength, and bean type can all shift the true caffeine dose.
How to read the evidence
The strongest anchors in this research are the verified cohort size of 131,821 participants, the 11,033 confirmed dementia cases, and the 43-year follow-up window, all confirmed in the JAMA record and institutional reporting from the Harvard Gazette. These numbers establish the study’s scale and duration, which exceed most prior investigations into coffee and cognitive decline.
The risk-reduction percentages carry more uncertainty. Both the 35% and 18% figures come from adjusted hazard ratios, statistical estimates that depend on modeling choices the authors made about which variables to control for. Adjusted hazard ratios are standard tools in epidemiology, but they are not the same as a measured effect from a randomized trial. No randomized controlled trial has tested whether assigning people to drink two to three cups of coffee daily for decades would reduce dementia diagnoses, and such a trial would be extraordinarily difficult to conduct.
One plausible biological mechanism involves caffeine’s effect on cerebral blood flow. Short-term studies have shown that caffeine increases alertness and modestly alters blood perfusion in the brain, but whether those acute changes translate into long-term protection against neurodegeneration is unproven. Other hypotheses focus on coffee’s polyphenols and antioxidant compounds, which might help reduce inflammation or oxidative stress in neural tissue. At this stage, however, the JAMA authors and commentators alike emphasize that mechanistic explanations are speculative.
The study also examined tea intake and decaffeinated coffee, though the clearest associations were seen with caffeinated coffee. Tea drinkers showed smaller and less consistent reductions in dementia risk, and decaf coffee did not display the same pattern as its caffeinated counterpart. These nuances suggest that caffeine itself, or compounds that co-occur with caffeine in coffee, could be driving at least part of the observed relationship, but they do not rule out lifestyle differences between beverage preferences.
Implications for everyday coffee drinkers
For individuals who already enjoy coffee, the findings offer some reassurance. Moderate daily consumption-on the order of two to three cups-appears compatible with healthy aging for most adults and may be linked to a lower likelihood of dementia later in life. People who metabolize caffeine well and do not experience side effects such as palpitations, insomnia, or anxiety can reasonably view coffee as one small part of an overall brain-healthy lifestyle.
That lifestyle still rests on better-established pillars: regular physical activity, blood pressure and cholesterol control, not smoking, and managing conditions like diabetes and sleep apnea. Compared with these factors, coffee intake is likely a relatively minor contributor, and the new data do not justify starting to drink coffee solely as a dementia-prevention strategy, especially for those who dislike it or are sensitive to caffeine.
Those who do choose to drink coffee should remember that preparation matters. Large specialty drinks that combine coffee with substantial amounts of sugar and cream can add hundreds of calories and may worsen cardiovascular risk, potentially offsetting any small cognitive benefit. Plain brewed coffee or coffee with modest additions of milk is more consistent with the patterns observed in the health professional cohorts.
What comes next in coffee and cognition research
The authors of the JAMA paper, whose work can also be accessed through the journal’s digital object identifier, call for further studies in more diverse populations. The current cohorts are predominantly health professionals, a group that tends to have higher education levels, better access to medical care, and possibly healthier baseline behaviors than the general public. Replicating these findings in broader and more varied communities will be essential before drawing firm public health conclusions.
Future research may also focus on intermediate outcomes, such as changes in cognitive test scores over time or brain imaging markers, rather than waiting for clinical dementia diagnoses. Shorter trials that assign participants to different levels of coffee or caffeine intake and then track memory performance, attention, or structural brain changes could help clarify whether coffee has a direct neuroprotective effect or simply travels alongside other healthy habits.
For now, the message is measured but encouraging. Long-term observational data from more than 130,000 adults suggest that moderate coffee drinking is at least compatible with healthy brain aging and may be associated with a lower risk of dementia, particularly before age 75. The evidence is not strong enough to treat coffee as medicine, but it does support the idea that, for many people, a daily cup or two can fit comfortably within a lifestyle aimed at preserving cognitive health well into older age.
